Host and virological characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection

被引:4
|
作者
Huang, Chung-Feng [1 ,2 ]
Huang, Ching-I [1 ,3 ]
Yeh, Ming-Lun [3 ]
Huang, Jee-Fu [3 ,4 ]
Hsieh, Ming-Yen [3 ]
Lin, Zu-Yau [3 ,4 ]
Chen, Shinn-Cherng [3 ,4 ]
Yu, Ming-Lung [3 ,4 ]
Dai, Chia-Yen [3 ,4 ,5 ,6 ]
Chuang, Wan-Long [3 ,4 ]
机构
[1] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Occupat Med, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Coll Med, Fac Internal Med, Sch Med, Kaohsiung, Taiwan
[5] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Occupat Med, Kaohsiung, Taiwan
[6] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Prevent Med, Kaohsiung, Taiwan
关键词
Genotype; Hepatitis C virus; Interleukin-28B; Mixed infection; INTERLEUKIN-28B GENETIC-VARIANTS; HEPATOCELLULAR-CARCINOMA; RIBAVIRIN THERAPY; VIRAL-HEPATITIS; HCV; INTERFERON; IL28B; SUPERINFECTION; POLYMORPHISMS; ASSOCIATION;
D O I
10.1016/j.kjms.2015.02.004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The prevalence and characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection (HCV-1/ 2) remains unclear. For each HCV-1/ 2 patient with histological data available, two age-and sex-matched HCV-1 and HCV-2 infected patients were selected for comparison, respectively. Of the 2776 patients, 261 (9.4%) patients were identified as having mixed HCV-1/ 2 infection. The histological severity did not differ among HCV-1/ 2 patients and controls. The proportion of patients with the interleukin-28B (IL-28B) rs8099917 TT genotype did not differ between patients with mixed-1/ 2 and HCV-1 infection (82.6% vs. 86.5%, p = 0.38). However, HCV-2 infected patients had a significantly higher proportion of the rs8099917 TT genotype compared to patients with mixed HCV-1/ 2 infections (91.6% vs. 82.6%, p = 0.03). The HCV RNA levels were similar in patients with HCV-1/ 2 and HCV-1 infections (5.5 +/- 0.8 log IU/mL vs. 5.5 +/- 0.9 log IU/L, p = 0.73), which were both significantly higher than that of HCV-2 infection (5.1 +/- 0.9 log IU/mL, both p < 0.001). Linear regression analysis revealed that the factors of HCV-1/2 infection [beta: 0.204; 95% confidence interval (CI): 0.183-0.598, p < 0.001], bodyweight(beta:0.150;CI: 0.003-0.021, p = 0.008), and age (beta: - 0.139; CI: - 0.020 to - 0.002, p = 0.01) were independently correlated with HCV RNA levels in patients with HCV-2 and mixed HCV-1/2 infection. We concluded that the host genetic and viral presentations of patients with mixed HCV-1/2 infection were more similar to those of patients with HCV-1 infection than patients with HCV-2 infection. Copyright (C) 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
引用
收藏
页码:271 / 277
页数:7
相关论文
共 50 条
  • [21] Clinical, virological and histological implications of GB virus-C/hepatitis G virus infection in patients with chronic hepatitis C virus infection: a multicentre study based on 671 patients
    Slimane, SB
    Albrecht, JK
    Fang, JWS
    Goodman, Z
    Mizokami, M
    Qian, K
    Lau, JYN
    JOURNAL OF VIRAL HEPATITIS, 2000, 7 (01) : 51 - 55
  • [22] The Host Factor Erlin-1 is Required for Efficient Hepatitis C Virus Infection
    Whitten-Bauer, Christina
    Chung, Josan
    Gomez-Moreno, Andoni
    Gomollon-Zueco, Pilar
    Huber, Michael D.
    Gerace, Larry
    Garaigorta, Urtzi
    CELLS, 2019, 8 (12)
  • [23] Sustained virological response of patients with hepatitis C virus genotype 2 depends on pegylated interferon compliance
    Watanabe, Takao
    Konishi, Ichiro
    Shigematsu, Shuichiro
    Uesugi, Kazuhiro
    Joko, Kouji
    Seike, Hirotaka
    Okada, Shinichi
    Miyaoka, Hiroaki
    Nakanishi, Seiji
    Abe, Masanori
    Matsuura, Bunzo
    Michitaka, Kojiro
    Horiike, Norio
    Hiasa, Yoichi
    Onji, Morikazu
    HEPATOLOGY RESEARCH, 2011, 41 (08) : 722 - 730
  • [24] Safety and efficacy of glecaprevir and pibrentasvir in north Tohoku Japanese patients with genotype 1/2 hepatitis C virus infection
    Miyasaka, Akio
    Yoshida, Yuichi
    Murakami, Akihiko
    Hoshino, Takao
    Sawara, Kei
    Numao, Hiroshi
    Takikawa, Yasuhiro
    HEALTH SCIENCE REPORTS, 2022, 5 (01)
  • [25] Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection
    Hsu, Ching-Sheng
    Liu, Chen-Hua
    Liu, Chun-Jen
    Hsu, Shih-Jer
    Chen, Chi-Ling
    Hwang, Juey-Jen
    Lai, Ming-Yang
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (05) : 970 - 977
  • [26] Hepatitis C virus infection: are there still specific problems with genotype 3?
    Gondeau, Claire
    Pageaux, Georges Philippe
    Larrey, Dominique
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (42) : 12101 - 12113
  • [27] Hepatitis C virus infection:are there still specific problems with genotype 3?
    Claire Gondeau
    Georges Philippe Pageaux
    Dominique Larrey
    World Journal of Gastroenterology, 2015, (42) : 12101 - 12113
  • [28] The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection
    Covolo, L.
    Bibert, S.
    Donato, F.
    Bochud, P. -Y.
    Lagging, M.
    Negro, F.
    Fattovich, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (03) : 322 - 330
  • [29] Changes in Hepatitis C Virus Genotype Distribution in Chronic Hepatitis C Infection Patients
    Selek, Mehmet Burak
    Baylan, Orhan
    Karagoz, Ergenekon
    Ozyurt, Mustafa
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 36 (03) : 416 - 421
  • [30] Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis
    Rutledge, Stephanie M.
    Chung, Raymond T.
    Sise, Meghan E.
    HEMODIALYSIS INTERNATIONAL, 2018, 22 : S81 - S96